Health Trials

Insulin Aspart

1

Review clinical trials related to Insulin Aspart. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

This study is a randomized, double-blinded, two-treatment, two-period, two-sequence crossover pivotal Biosimilar study. The purpose of this study is to establish pharmacokinetic (PK) and pharmacodynamic (PD) biosimilarity of proposed biosimilar I004 and the US-approved NovoLog.

Participants needed: 60
Trial details
Phase: Phase 2, Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Amphastar Pharmaceuticals, Inc.Updated: Apr 30, 2026Locations: 1
Eligibility criteria

Upon review, agree to participate and sign informed consent. [+7]

History of diabetes mellitus. [+20]

Read more